Concepedia

Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (<scp>CRSwNP</scp>) over 3 years

Patrick Huber, Ulrike Förster‐Ruhrmann, Heidi Olze, Sven Becker, Friederike Bärhold, Mandy Cuevas, Nadine Gunder, Jan Hagemann, Christoph Matthias, Ludger Klimek,

Allergy · 2024 · 16 citations · 20 references

DOIFull text

Open access

Abstract

The study highlights the enduring effectiveness and lack of habituation to dupilumab after a sustained therapy of 3 years, providing valuable insights into its long-term therapeutic implications for CRSwNP patients.

References

20

European Position Paper on Rhinosinusitis and Nasal Polyps 2020

W.J. Fokkens, Valerie J. Lund, C. Hopkins et al. · Rhinology Journal · 2020 · 5.4K citations · Full text

Psychometric validity of the 22‐item Sinonasal Outcome Test

Claire Hopkins, S. Gillett, R Slack et al. · Clinical Otolaryngology · 2009 · 1.5K citations

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert, Joseph K. Han, Martin Desrosiers et al. · The Lancet · 2019 · 1.4K citations

, , +7

Oral steroids and doxycycline: Two different approaches to treat nasal polyps

Thibaut Van Zele, Philippe Gevaert, Gabriële Holtappels et al. · Journal of Allergy and Clinical Immunology · 2010 · 400 citations

, , +6

Chronic Rhinosinusitis with Nasal Polyps and Asthma

Tanya M. Laidlaw, Joaquim Mullol, Katharine M. Woessner et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 365 citations · Full text

, , +12